Israeli-Founded AI Biotech Immunai Collaborates with Boehringer Ingelheim

Israeli-founded AI biotech company Immunai has launched a drug-discovery collaboration with Boehringer Ingelheim, utilizing Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.